RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer ProgramAs ONCY stated in today's press release ..
" We are now well-positioned to deliver on our mission of making pelareorep available to breast cancer patients in need of better treatment options."